{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"2.4","upperLimit":"7.0","value":"4.2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"}],"units":"Participants"}],"description":"Overall Survival using the Kaplan-Meier method","dispersionType":"95% Confidence Interval","groups":[{"description":"Gemcitabine given 3000 mg/m2 IV over 30 minutes and Docetaxel given 60mg/m2 IV over 60 minutes. The Docetaxel should be administered after the Gemcitabine.","id":"OG000","title":"Gemcitabine, Docetaxel"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Every 8 weeks","title":"Survival","type":"SECONDARY","unitOfMeasure":"months"}